Get New Biotechnology Exposure with the GDNA ETF

By: ETFdb
The coronavirus pandemic is certainly putting healthcare in the spotlight, but it’s also putting biotechnology under the proverbial microscope, particularly when it comes to finding a vaccine. As such, exchange-traded fund (ETF) investors can get next-level biotech exposure with funds like the Goldman Sachs Human Evolution ETF ( GDNA ).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.